Search clinical trials for: tiotropium Respimat® inhaler
Total 217 results
-
Boehringer IngelheimCompletedCystic FibrosisUnited States, Australia, Austria, Belgium, Canada, Czech Republic, France, Germany, Hungary, Ireland, Israel, Italy, Poland, Portugal, Russian Federation, Slovakia, South Africa, Spain, Switzerland, United Kingdom
-
Boehringer IngelheimCompleted12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPDPulmonary Disease, Chronic ObstructiveGermany, Italy, Switzerland, South Africa
-
Boehringer IngelheimCompleted12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPDPulmonary Disease, Chronic ObstructiveCanada, United States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada, Germany
-
University of TorontoUniversity Health Network, Toronto; Thornhill ResearchUnknownIntraocular PressureCanada
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Chile, Germany, Hungary, Italy, Korea, Republic of, Latvia, Mexico, Russian Federation, Slovakia, Spain, Ukraine
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Canada, Finland, France, Germany, Hungary, Italy, Spain, United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Germany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveChina
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Brazil, China, Guatemala, India, Japan, Latvia, Mexico, Peru, Poland, Russian Federation
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Brazil, China, Colombia, Germany, India, Japan, Mexico, Peru, Poland, Romania
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveItaly
-
Irmandade Santa Casa de Misericórdia de Porto AlegreNovartisCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
Boehringer IngelheimTerminatedPulmonary Disease, Chronic ObstructiveSwitzerland
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveIsrael, Russian Federation, Ukraine, Bulgaria, Czechia, Hungary, Lithuania, Poland, Romania, Slovenia, Switzerland
-
Boehringer IngelheimCompleted
-
Erasme University HospitalCompletedPulmonary Disease, Chronic ObstructiveBelgium
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveKorea, Republic of
-
Boehringer IngelheimPfizerCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGreece
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Austria, Canada, Germany, Netherlands, Russian Federation, Sweden
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Austria, Belgium, Canada, Chile, Germany, Italy, New Zealand
-
Fundacion Clinic per a la Recerca BiomédicaNot yet recruiting
-
RWTH Aachen UniversityWithdrawn
-
Glenmark Specialty S.A.CompletedMild to Moderate Chronic Obstructive Pulmonary Disease (COPD)United States
-
Imperial College LondonBoehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Novartis PharmaceuticalsWithdrawnPulmonary Disease, Chronic Obstructive
-
Lundquist Institute for Biomedical Innovation at...Boehringer IngelheimCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Denmark, Germany, Hungary, Netherlands
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveDenmark, Netherlands, Finland, Belgium, Germany, Norway
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveChina
-
Pearl Therapeutics, Inc.Completed
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Bulgaria, Canada, China, Czech Republic, Denmark, Estonia, Finland, France, Germany, Guatemala, Hungary, India, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Portugal, Russian... and more
-
University of DundeeCompleted
-
3MQuotient ClinicalCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Brazil, Canada, China, Denmark, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Ireland, Italy, Korea, Republic of, Lithuania, Malaysia, Mexico, Netherlands, Norway, Portugal, Singapore, Slovakia, South... and more
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveCanada, Germany, Netherlands, Sweden